1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Life...

Let's Pass it on...

Know More

Organs wasted are lives lost....

Become an Organ Donor-Saves Lives...

Know More

Don't Take your organs to Heaven...

Know More

Organ Donation

If you save one life,It is as though you save the world

27Jan/12

FDA Approves Inlyta To Treat Patients With a Type of Advanced Kidney Cancer – Sacramento Bee

January 27, 2012Immunosuppressive Drugsadmin

WANEFDA Approves Inlyta To Treat Patients With a Type of Advanced Kidney CancerSacramento BeeRecently approved drugs for the treatment of kidney cancer include sorafenib (2005), sunitinib (2006), temsirolimus (2007), everolimus (2009), bevacizumab (200…

27Jan/12

Steroid-Sparing Renal Transplant Yields Successful Outcomes – Doctors Lounge

January 27, 2012Transplant Rejectionadmin

Steroid-Sparing Renal Transplant Yields Successful OutcomesDoctors LoungeAcute rejection rates were 31 and 25 percent, respectively, and chronic rejection due to interstitial fibrosis/tubular atrophy occurred in 47 and 39 percent of LD and DD recipient…

27Jan/12

Q&A: What does Ontario's first cardiac stem cell transplant mean for Canadians? – Global Toronto

January 27, 2012Other Transplantationadmin

The Express TribuneQ&A: What does Ontario's first cardiac stem cell transplant mean for Canadians?Global TorontoToronto doctors have performed Ontario's first cardiac stem cell transplant using bone marrow cells of the patient in question. …

27Jan/12

Sycamore Shoals Hospital receives certification for congestive heart failure … – Elizabethton Star

January 27, 2012Organ Failureadmin

Sycamore Shoals Hospital receives certification for congestive heart failure …Elizabethton StarBy Ashley Rader Sycamore Shoals Hospital recently received the Joint Commission's Advanced Certification for congestive heart failure for its high-qual…

27Jan/12

Regenerative medicine company encouraged by heart failure trial – MedCity News

January 27, 2012Organ Failureadmin

Regenerative medicine company encouraged by heart failure trialMedCity NewsRegenerative medicine company Juventas Therapeutics is touting the results from 12-month data of a phase 1 clinical trial of heart failure patients. At 12 months, heart failure …

27Jan/12

Kidney Donor Gives Organ to Stranger on a Whim – ABC News

January 27, 2012Transplant Surgeryadmin

ABC NewsKidney Donor Gives Organ to Stranger on a WhimABC NewsBut last June, the 55-year-old professor gave doctoral student John Young — a virtual stranger — her kidney, enduring every invasive test and eventually transplant surgery to save his life…

27Jan/12

Oakdale Legislators Address PFCs, Government Efficiency, Organ Donation in New … – Patch.com

January 27, 2012Organ Donoradmin

Oakdale Legislators Address PFCs, Government Efficiency, Organ Donation in New …Patch.comChuck Wiger, would create a license plate that says “Become an organ donor and save a life.” To get the plates, drivers would have to pay a $10 fee, plus mak…

27Jan/12

Takeda's Orteronel (TAK-700) Enters Phase III Clinical Trials For Prostate Cancer – Asian Scientist Magazine

January 27, 2012Immunosuppressive Drugsadmin

Asian Scientist MagazineTakeda's Orteronel (TAK-700) Enters Phase III Clinical Trials For Prostate CancerAsian Scientist MagazineThe first (C21004) is a randomized, double-blind and multi-center trial of prednisolone plus orteronel or placebo in pa…

27Jan/12

ImmunoGen, Inc. Reports Second Quarter Fiscal Year 2012 Financial Results and … – MarketWatch (press release)

January 27, 2012Monoclonal Anti-CD20 Antibodiesadmin

ImmunoGen, Inc. Reports Second Quarter Fiscal Year 2012 Financial Results and …MarketWatch (press release)Phase II trials are now in process that evaluate SAR3419: (1) as a single agent for diffuse large B-cell lymphoma (DLBCL); (2) in combination wi…

27Jan/12

Bristol-Myers fourth quarter below analysts estimates – The Pharma Letter

January 27, 2012Transplant Rejectionadmin

The Star-Ledger – NJ.comBristol-Myers fourth quarter below analysts estimatesThe Pharma LetterThis concludes a year in which the company received important new product approvals for Yervoy (ipilimumab) for the treatment of metastatic melanoma and kidne…

Posts navigation

  • « Previous
  • 1
  • …
  • 17,823
  • 17,824
  • 17,825
  • 17,826
  • 17,827
  • …
  • 18,200
  • Next »

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos